Development of a capillary electrophoresis method for the determination of orphenadrine citrate in tablets in the presence of paracetamol

Saudi Pharmaceutical Journal

Volumn 18, Issue 4, 2010, Pages 233-237

  Haj Ali, Dana N ^a   Hamdan, Imad I ^a  

^a UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Capillary electrophoresis; Orphinadrine citrate; Paracetamol

Indexed keywords

4 MORPHOLINOPROPANESULFONIC ACID; ALKANE DERIVATIVE; DODECYL SULFATE SODIUM; MORPHOLINE DERIVATIVE; MYOGESIC; NORGESIC; ORPHENADRINE CITRATE; PARACETAMOL; PENTANESULFONATE SODIUM; PSEUDOEPHEDRINE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CAPILLARY ELECTROPHORESIS; DRUG DEGRADATION; DRUG DETERMINATION; DRUG MIXTURE; DRUG STRUCTURE; HYDRODYNAMICS; PH; TABLET FORMULATION; VALIDATION PROCESS;

EID: 84755161401     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2010.07.007     Document Type: Article

References (22)

1. Ahmad I., Yaqoob N., Awan S., Aman T. First order derivative spectrophotometric determination of orphenadrine citrate in pure and pharmaceutical preparation. J. Chem. Soc. Pak. 2005, 27(4):388-392.
2. Arayne M., Sultana N., Siddiqui F. Simultaneous determination of paracetamol and orphenadrine citrate in dosage formulations and in human serum by RP-HPLC. J. Chin. Chem. Soc. 2009, 56(1):169-174.
3. Bilzer W., Gundert-Remy U. Determination of nanogram quantities of diphenhydramine and orphenadrine in human plasma using gas-liquid chromatography. Eur. J. Clin. Pharmacol. 1973, 6:268-270.
4. British Pharmacopoeia. Royal Pharmaceutical Press, London, UK, 1980.
5. Contin M., Riva R., Albani F., Baruzzi A. Simple and rapid GLC method for the determination of orphenadrine in human plasma. Biomed. Chromatogr. 1988, 2(5):193-194.
6. ICH Q1A: Stability Testing of New Drug Substances and Products. (International Conference on Harmonization of Technical Requirements for the Registration of Drugs for Human Use, Geneva, Switzerland, February 2003.
7. Labout J., Thussen C., Hespe W. Sensitive and specific gas chromatographic and extraction method for the determination of orphenadrine in human body fluids. J. Chromatogr. A 1977, 144(2):201-208.
8. Lee S.-Y., Oh H.J., Kim J.W., Kim Y.J., Moon C.J., Lee E.H. Pharmacokinetic study of orphenadrine using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). J. Chromatogr. B 2006, 839:118-123.
9. Lutz D., Gielsdorf W., Jaeger H. Quantitative determination of diphenhydramine and orphenadrine in human serum by capillary gas chromatography. J. Clin. Chem. Clin. Biochem. 1983, 21(10):595-597.
10. McGuinness B.W. A double-blind comparison in general practice of a combination tablet containing orphenadrine citrate and paracetamol with paracetamol alone. J. Int. Med. Res. 1983, 11:42-45.
11. Moffat, A.C., Jackson, J., Moss, M., Widdop, B., 1986. Clarke's isolation and identification of drugs in pharmaceuticals body fluids and post-mortem material, second ed. The Pharmaceutical Press, London.
12. Mok M.S., Lippmann M., Steen S.N. Drug combinations with orphenadrine. Clin. Ther. 1979, 2:188-193.
13. Righetti P. Capillary Electrophoresis in Analytical Biotechnology 1996, CRC Press, LLC, Florida. first ed.
14. Rumore M., Schlichting D. Clinical efficacy of antihistaminics as analgesics. Pain 1986, 25:1-22.
15. Saleh H., EL-Henawee M., Ragab G., Abd El-Hay S. Utility of NBD-Cl for the spectrophotometric determination of some skeletal muscle relaxant and antihistaminic drugs. Spectrochim. Acta A 2007, 67:1284-1289.
16. Selkirk S., Fell A., Smith G., Miller J. Stability-indicating assay for orphenadrine hydrochloride by reversed-phase high-performance liquid chromatography. J. Chromatogr. A 1984, 288:431-444.
17. Shama S. Spectrophotometric determination of phenylephrine HCl and orphenadrine citrate in pure and in dosage forms. J. Pharm. Biomed. Anal. 2002, 30:1385-1392.
18. Sharaf El-Din M., Abuirjeie M., Abdel-Hay M. Simultaneous determination of acetaminophen with orphenadrine citrate, ibuprofen or chlorzoxazone in combined dosage forms by zero-crossing derivative spectrophotometry. Anal. Lett. 1991, 24(12):2187-2206.
19. Sheikh Salem M., Alkaysi H., Gharaibeh A. Quantitation of orphenaorine citrate and acetaminophen in tablet formulation using thin layer chromatography densitometry. Anal. Lett. 1989, 22(3):585-596.
20. The United States Pharmacopeia, 31th Revision, United States Pharmacopeial Convention Inc., Rockville, MD, 2008.
21. Waldman H. Centrally acting skeletal muscle relaxants and associated drugs. J. Pain Symp. Manage. 1994, 9(7):434-441.
22. Wallace M. Pain Medicine and Management: Just the Facts 2004, McGraw-Hill Professional, OH, USA.